Back
Corcept Therapeutics Stock Price Chart
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
73
CORT
Corcept Therapeutics
Last Price:
42.21
Seasonality Move:
-0.77%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing slight selling pressure.
Corcept Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.46 | Buy |
| 20-day SMA: | 35.35 | Buy |
| 50-day SMA: | 34.63 | Buy |
| 200-day SMA: | 28.35 | Buy |
| 8-day EMA: | 37.09 | Buy |
| 20-day EMA: | 35.82 | Buy |
| 50-day EMA: | 34.38 | Buy |
| 200-day EMA: | 29.93 | Buy |
Corcept Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.97 | Buy |
| Relative Strength Index (14 RSI): | 76.64 | Buy |
| Chaikin Money Flow: | -527200 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.69 - 36.57) | Buy |
| Bollinger Bands (100): | (27.98 - 35.64) | Buy |
Corcept Therapeutics Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Corcept Therapeutics Stock
Is Corcept Therapeutics Stock a Buy?
- Corcept Therapeutics share price is 39.71 while CORT 8-day simple moving average is 36.46, which is a Buy signal.
- The stock price of CORT is 39.71 while Corcept Therapeutics 20-day SMA is 35.35, which makes it a Buy.
- Corcept Therapeutics 50-day simple moving average is 34.63 while CORT share price is 39.71, making it a Buy technically.
- CORT stock price is 39.71 and Corcept Therapeutics 200-day simple moving average is 28.35, creating a Buy signal.
CORT Technical Analysis vs Fundamental Analysis
Buy
73
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy or a Sell?
-
Corcept Therapeutics stock is rated a Buy
The current Corcept Therapeutics [CORT] share price is $39.71. The Score for CORT is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
Corcept Therapeutics Stock Info
Market Cap:
4.15B
Price in USD:
39.71
Share Volume:
1.42M
Corcept Therapeutics 52-Week Range
52-Week High:
41.95
52-Week Low:
20.84
Buy
73
Corcept Therapeutics (CORT)
is a Buy
Corcept Therapeutics Share Price Forecast
-
What is the Corcept Therapeutics stock price today?
The Corcept Therapeutics stock price is 39.71 USD today. -
Will CORT stock go up or go down?
Corcept Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Corcept Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Corcept Therapeutics is not overvalued.
Is Corcept Therapeutics Stock a Buy?
- Corcept Therapeutics share price is 39.71 while CORT 8-day exponential moving average is 37.09, which is a Buy signal.
- The stock price of CORT is 39.71 while Corcept Therapeutics 20-day EMA is 35.82, which makes it a Buy.
- Corcept Therapeutics 50-day exponential moving average is 34.38 while CORT share price is 39.71, making it a Buy technically.
- CORT stock price is 39.71 and Corcept Therapeutics 200-day simple moving average is 29.93, creating a Buy signal.
Fundamental Analysis of Corcept Therapeutics
Is Corcept Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.15 per share, an increase this year of $0.22 per share, and an increase next year of $0.59 per share.
Technical Analysis of Corcept Therapeutics
Should I short Corcept Therapeutics stock?
- CORT Moving Average Covergence Divergence (MACD) indicator is 0.97, suggesting Corcept Therapeutics is a Buy
- Corcept Therapeutics Relative Strength Index (RSI) is 76.64, which suggest Corcept Therapeutics is overbought
- The Bollinger Bands (25) for Corcept Therapeutics is (33.69 - 36.57), which suggest Corcept Therapeutics is a Buy
- The Bollinger Bands (100) for Corcept Therapeutics is (27.98 - 35.64), which suggest Corcept Therapeutics is a Buy
* Corcept Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.